You have no items in your shopping cart.
Availability: In Stock
Brand Name : Xipenz 500mg/500mg Injection
Composition : Imipenem (500mg), Cilastatin (500mg)
Manufactured By : Hetero Drugs Ltd
Form : vial
Packing : 1 Injection in 1 vial
Xipenz 500mg/500mg Injection Description:
Xipenz 500mg/500mg Injection is a combination of two medicines: Imipenem and Cilastatin. Imipenem is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Cilastatin is dehydropeptidase I inhibitor which blocks the activity of an enzyme (dehydropeptidase I) that causes breakdown of Imipenem. Hence, it helps Imipenem stay active in your body for a longer period of time.
Xipenz 500mg/500mg Injection is used in the treatment of serious bacterial infections.
Nausea, Vomiting, Diarrhoea, Rash.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Buy Xipenz 500mg/500mg Injection Online From India At Best Price
If you are looking to buy Imipenem (500mg), Cilastatin (500mg) (1 Injection in 1 vial) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.
Order Online to Get Xipenz 500mg/500mg Injection in -
South East Asia - China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.
United Arab Emirates (UAE) - Iran, Saudi Arabia, Jordan.
North America - Venezuela, USA (United States of America), Suriname.
South America - Argentina, Chile, Colombia, Peru, Venezuela.
Europe - Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.
Russia CIS - Moldova, Uzbekistan, Kyrgyzstan.
African Countries - Nigeria, Kenya, Morocco, Libya, Zimbabwe.
Other Countries - Malaysia, Egypt, Australia, Italy and New Zealand.